Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes
Qi Peng(Guy's Hospital), Jiaming Fan(Children's Hospital of Chongqing Medical University), Ailong Huang(Dalian Medical University), Lan Zhou(Chongqing Medical University), Jinyong Luo(Children's Hospital of Chongqing Medical University), Tong‐Chuan He(Foundation for the National Institutes of Health), Hao Wang(University of South Florida), Yetao Luo(Children's Hospital of Chongqing Medical University), Bin Chen(Children's Hospital of Chongqing Medical University), Qiong Shi(Air Force Medical University), Ying Zhu(Jiangsu Cancer Hospital), Jinghong Wu(Children's Hospital of Chongqing Medical University), Guowei Zuo(Chongqing Medical University), Yaguang Weng(Chongqing Medical University)
Cited by 38
Related Papers
Antibody responses to SARS-CoV-2 in patients with COVID-19
|Nature Medicine|2020|3.1k
Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs)
|Cellular Physiology and Biochemistry|2017|2.8k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system
|Nature Protocols|2007|869
3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends
|Genes & Diseases|2017|678